KR102350423B1 - 세포 동결 보존 제제 및 세포 소생 방법 - Google Patents

세포 동결 보존 제제 및 세포 소생 방법 Download PDF

Info

Publication number
KR102350423B1
KR102350423B1 KR1020197038096A KR20197038096A KR102350423B1 KR 102350423 B1 KR102350423 B1 KR 102350423B1 KR 1020197038096 A KR1020197038096 A KR 1020197038096A KR 20197038096 A KR20197038096 A KR 20197038096A KR 102350423 B1 KR102350423 B1 KR 102350423B1
Authority
KR
South Korea
Prior art keywords
cryopreservation
cell
formulation
solution
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197038096A
Other languages
English (en)
Korean (ko)
Other versions
KR20200073171A (ko
Inventor
리 장
페이 왕
지아핑 허
난징 린
리핑 리우
신 리우
차오 리
슈치엔 위
용라이 후
지아웨이 자오
저 순
시아오위 리우
Original Assignee
셀룰라 바이오메디신 그룹 (상하이) 리미티드
셀룰라 바이오메디신 그룹 (우시) 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 셀룰라 바이오메디신 그룹 (상하이) 리미티드, 셀룰라 바이오메디신 그룹 (우시) 리미티드 filed Critical 셀룰라 바이오메디신 그룹 (상하이) 리미티드
Publication of KR20200073171A publication Critical patent/KR20200073171A/ko
Application granted granted Critical
Publication of KR102350423B1 publication Critical patent/KR102350423B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A01N1/02—
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/31—Chimeric antigen receptors [CAR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/428—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
KR1020197038096A 2017-05-24 2018-05-24 세포 동결 보존 제제 및 세포 소생 방법 Active KR102350423B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201710375424.X 2017-05-24
CN201710375424.XA CN108925548A (zh) 2017-05-24 2017-05-24 一种冻存细胞制剂及细胞复苏方式
PCT/CN2018/088246 WO2018214943A1 (zh) 2017-05-24 2018-05-24 一种冻存细胞制剂及细胞复苏方式

Publications (2)

Publication Number Publication Date
KR20200073171A KR20200073171A (ko) 2020-06-23
KR102350423B1 true KR102350423B1 (ko) 2022-01-11

Family

ID=64396262

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197038096A Active KR102350423B1 (ko) 2017-05-24 2018-05-24 세포 동결 보존 제제 및 세포 소생 방법

Country Status (8)

Country Link
US (1) US20200170242A1 (enExample)
EP (1) EP3632207A4 (enExample)
JP (1) JP7303184B2 (enExample)
KR (1) KR102350423B1 (enExample)
CN (1) CN108925548A (enExample)
AU (1) AU2018272688B2 (enExample)
NZ (1) NZ759568A (enExample)
WO (1) WO2018214943A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110679588A (zh) * 2019-10-23 2020-01-14 厦门生命互联科技有限公司 一种嵌合抗原受体t细胞冻存介质及用途
WO2021201029A1 (ja) * 2020-03-31 2021-10-07 Ｃｅｌｌ Ｅｘｏｓｏｍｅ Ｔｈｅｒａｐｅｕｔｉｃｓ株式会社 細胞の保存方法
US20240018482A1 (en) * 2020-08-10 2024-01-18 Angiocrine Bioscience, Inc. Cryopreserved endothelial cell compositions
TW202245811A (zh) * 2021-02-03 2022-12-01 美商異基因治療有限公司 用於ｃａｒ ｔ細胞藥物產品的調配物與製程
US20220354108A1 (en) * 2021-05-04 2022-11-10 Tissue Testing Technologies Llc Preservation methods using trehalose with other cryoprotectants being absent from the cryopreservation protocol
CN113994951A (zh) * 2021-11-17 2022-02-01 晋文娟 一种cik细胞冻存液及冻存方法
CN114097771B (zh) * 2021-12-15 2022-10-14 珠海贝索细胞科学技术有限公司 一种细胞保存液及其应用和细胞保存方法
CN115136955A (zh) * 2022-08-03 2022-10-04 深圳宾德生物技术有限公司 细胞冻存液及其制备方法和应用
CN116058363B (zh) * 2023-01-13 2025-10-28 杭州中赢生物医疗科技有限公司 一种增加nk细胞冻存复苏后活性的方法及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105477017A (zh) * 2015-12-03 2016-04-13 深圳爱生再生医学科技有限公司 治疗糖尿病足的混合干细胞制剂及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713245B2 (en) * 1998-07-06 2004-03-30 Diacrin, Inc. Methods for storing neural cells such that they are suitable for transplantation
US20030054331A1 (en) * 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
US7270946B2 (en) * 2002-10-04 2007-09-18 Organ Recovery Systems, Inc. Method for treatment of cellular materials with sugars prior to preservation
US7176022B2 (en) * 2002-12-20 2007-02-13 Cell Genesys, Inc. Directly injectable formulations which provide enhanced cryoprotection of cell products
US20070025961A1 (en) 2003-06-03 2007-02-01 Kenzo Bamba Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survival of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf
CN102119936B (zh) * 2011-03-07 2012-12-12 李荣旗 制备利用人羊膜间充质细胞治疗缺血性脑损伤注射液的方法及其注射液
CN103461322B (zh) * 2012-06-07 2016-08-03 西比曼生物科技（上海）有限公司 用于冻存复苏后的细胞的保存液
CN102907416B (zh) * 2012-08-01 2016-08-03 西比曼生物科技（上海）有限公司 一种可维持细胞活性的组织冻存液
CN102792947B (zh) * 2012-09-03 2014-03-26 四川新生命干细胞科技股份有限公司 一种间充质干细胞冻存液及注射液
CN102908364A (zh) * 2012-11-14 2013-02-06 青岛奥克生物开发有限公司 一种间充质干细胞注射液及其制备方法和在制备治疗儿童扩张型心肌病药物中的应用
JP6643999B2 (ja) 2013-11-04 2020-02-12 アイソポジェン ピーティーワイ リミテッド 細胞培養方法
EP3167046A4 (en) 2014-07-07 2017-12-20 Targazyme Inc. Manufacture and cryopreservation of fucosylated cells for therapeutic use
CN104430301A (zh) * 2014-11-18 2015-03-25 成都康华生物制品有限公司 一种提高人二倍体细胞存活率的方法
EP3277296B1 (en) * 2015-04-02 2020-03-11 Stegi-Ra Trust Composition for use in treating celiac disease
CN104857022A (zh) * 2015-05-21 2015-08-26 北京青藤谷禧干细胞科技研究院有限公司 一种间充质干细胞注射液、制备方法及其应用
CN104873542A (zh) * 2015-05-21 2015-09-02 北京青藤谷禧干细胞科技研究院有限公司 一种脐带间充质干细胞注射液及其制备方法和应用
CN105394026B (zh) * 2015-10-31 2017-09-29 北京军科联合干细胞生物科技有限公司 一种造血干细胞冻存新方法
CN105325402A (zh) * 2015-11-13 2016-02-17 黄林海 一种用于玻璃化冻存骨髓间充质干细胞的冻存保护剂
CN105660606B (zh) * 2016-03-10 2018-04-03 广州赛莱拉干细胞科技股份有限公司 一种细胞冻存液
CN106177918A (zh) * 2016-09-30 2016-12-07 广州赛莱拉干细胞科技股份有限公司 一种间充质干细胞注射液及其制备方法和应用
CA3040123A1 (en) * 2016-10-11 2018-04-19 University Of Miami Vectors and vaccine cells for immunity against zika virus
CN106665560B (zh) * 2017-01-16 2021-02-05 哈尔滨医科大学 一种直接静脉回输的免疫细胞冻存液及其应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105477017A (zh) * 2015-12-03 2016-04-13 深圳爱生再生医学科技有限公司 治疗糖尿病足的混合干细胞制剂及其制备方法

Also Published As

Publication number Publication date
AU2018272688B2 (en) 2021-05-27
NZ759568A (en) 2023-01-27
EP3632207A1 (en) 2020-04-08
WO2018214943A1 (zh) 2018-11-29
CN108925548A (zh) 2018-12-04
US20200170242A1 (en) 2020-06-04
EP3632207A4 (en) 2021-03-10
KR20200073171A (ko) 2020-06-23
AU2018272688A1 (en) 2019-12-19
JP7303184B2 (ja) 2023-07-04
JP2020520680A (ja) 2020-07-16

Similar Documents

Publication Publication Date Title
KR102350423B1 (ko) 세포 동결 보존 제제 및 세포 소생 방법
CN104719282B (zh) 一种外周血单个核细胞无血清冻存液及冻存方法
US12414558B2 (en) Method for administering umbilical cord blood or peripheral blood
CN108207930B (zh) 一种鸡尾酒式冷冻保护剂及其应用
ES2588438T3 (es) Materiales y métodos para la recogida hipotérmica de sangre entera
CN105994254A (zh) 一种dc细胞的冻存液及冻存方法
CN110432259A (zh) 一种冷冻保护液和含有其的细胞冻存液及其在细胞冻存中的应用
CN105941389A (zh) 一种无动物源血清的细胞冻存液
CN109315386A (zh) 一种可用于造血干细胞或淋巴细胞的冻存液及冻存方法
Coriell et al. Historical development of cell and tissue culture freezing
WO2021190620A1 (zh) 细胞保存液及其试剂盒
Jović et al. Optimizing adipose-derived stromal vascular fraction storage: Temperature and time impact on cell viability in regenerative medicine
CN114403127A (zh) 一种间充质干细胞冷藏保护液及保存方法
CN101166541A (zh) 用于修复心脏组织的方法和组合物
Chaput et al. A clinical scalable cryopreservation method of adipose tissue for reconstructive surgery assessed by stromal vascular fraction and mice studies
CN207121593U (zh) 一种冻存细胞试剂盒
JPH057489A (ja) 動物細胞の凍結保存用血清不含培地及び保存方法
Ge et al. Skin graft preservation
CN105340877A (zh) 一种可使细胞长时间存活的细胞冷冻保护液、细胞制剂及制备方法
HK40017286A (en) Cell cryopreservation formulation and cell recovery method
NL2034495B1 (en) Stem cell cryopreservation protective agent, preparation method, and application thereof
CN106867877A (zh) 一种密闭式慢病毒载体培养装置和培养方法
Tovar et al. In vivo efficacy studies in cell line and patient-derived xenograft mouse models
JP2016533720A (ja) Ｎｋ−９２細胞株を保存および輸送するためのプロトコールおよび培地
Chen et al. Optimization of Rat Kidney Normothermic Machine Perfusion With Bovine Serum Albumin Perfusate: Improving Renal Function and Transplant Outcomes

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20191224

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210129

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20210831

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20210129

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20210831

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20210329

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20211229

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20211130

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20210831

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20210329

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220107

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220107

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20241223

Start annual number: 4

End annual number: 4